(PharmaNewsWire.Com, February 03, 2017 ) North America, followed by Europe, has the largest market for advanced wound management technologies due to developed healthcare infrastructure, technological advancement and rise in aging population in this region. Asia is expected to show high growth rate in the advanced wound management technologies market in next few years due to increasing incidence of chronic diseases, growing demand for better healthcare facilities and rise in patient population in the region.
Growing patient population, rise in need for improve method for acute and chronic wound management, reimbursement issue, technological advancement and increasing aging population are expected to drive the market for advanced wound management technologies. In addition, growing need for faster healing and rise in expectation for quality of life are expected to drive the market for advanced wound management technologies. However, high cost of advanced therapies and economic downturn are some of the major factors restraining the growth for global advanced wound management technologies market.
Growing demographics and economies in the developing countries such as Japan and India are expected to lead growth in advanced wound management technologies market in Asia. In addition, new developments and research, new innovations in wound care products and technologies, rise in adoption of advanced technologies due to more efficiency and effectiveness and increasing patient’s awareness about infections and advanced wound management technologies available in the market are expected to offer new opportunities for global advanced wound management technologies market. Increasing number of collaborations and partnerships, rise in number of mergers and acquisitions and new product launches are some of the latest trends that have been observed in global advanced wound management technologies market.
Some of the major companies operating in the global advanced wound management technologies market are 3M, Bard Medical Division, Coloplast A/S, Derma Sciences Inc., Hartmann Group, Shire Regenerative Medicine and Baxter International Inc. In addition, some other companies operating in global advanced wound management technologies market are Ethicon Inc., Smith & Nephew Plc, Convatec Inc. and Genzyme Corporation, a Sanofi company.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
